Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial (2024)
Attributed to:
The Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(23)00298-9
Publication URI: http://dx.doi.org/10.1016/s2665-9913(23)00298-9
Type: Journal Article/Review
Parent Publication: The Lancet Rheumatology
Issue: 2